Skip to content

Kobe Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurological Deficit Registry 2 (KASHER2)

Kobe Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurological Deficit Registry 2 (KASHER2) - Kobe Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurological Deficit Registry 2 (KASHER2)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044098
Enrollment
300
Registered
2021-05-03
Start date
2021-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

None listed

Sponsors

Kobe City Medical Center General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. subarachnoid hemorrage due to rupture of intracranial aneurysm 2. admitted to hospital within 14 days since last onset

Exclusion criteria

Exclusion criteria: No limitation

Design outcomes

Primary

MeasureTime frame
Frequency of cerebral infarction of delayed ischemic neurological disorder due to aneurysmal subarachnoid hemorrhage

Secondary

MeasureTime frame
1. Frequency of delayed ischemic neurological disorder due to aneurysmal subarachnoid hemorrhage 2. disabling stroke or death at 30days after admission or discharge 3. disabling stroke or death at 60days after admission 4. disabling stroke or death at 12months after admission 5. rebleeding of target aneurysm within 1 year 6. retreatment of target aneurysm within 1 year

Countries

Japan

Contacts

Public ContactNobuyuki Sakai

Kobe City Medical Center General Hospital Neurosurgery

n.sakai@siren.ocn.ne.jp078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026